Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Manoj Kanagaraj"'
Autor:
Aaron S. Kesselheim, Jessica M. Franklin, Manoj Kanagaraj, Elvira D’Andrea, Spencer Phillips Hey, Bishal Gyawali
Publikováno v:
J Natl Cancer Inst
Background The US Food and Drug Administration’s accelerated approval and later withdrawal of bevacizumab in patients with metastatic breast cancer (mBC) is a seminal case for ongoing debates about the validity of using progression-free survival (P
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d1ca22564976f1de3a91deb76cfa8854
https://doi.org/10.1093/jnci/djz211
https://doi.org/10.1093/jnci/djz211
Autor:
Christina Austin-Tse, Alan R. Shuldiner, Claudia Gonzaga-Jauregui, Noura S. Abul-Husn, Semanti Mukherjee, Samantha N. Fetterolf, Cristopher V. Van Hout, Monica A. Giovanni, Matthew S. Lebo, Omri Gottesman, Frederick E. Dewey, Thomas N. Person, Lukas Habegger, Korey A. Kost, Lance J. Adams, H. Lester Kirchner, James R. Elmore, Aris N. Economides, Christopher D. Still, Alexander H. Li, David J. Carey, Sarah A. Pendergrass, Anthony Marcketta, Jeffrey Staples, Marylyn D. Ritchie, Colm O'Dushlaine, Nehal Gosalia, Manoj Kanagaraj, William A. Faucett, John Penn, Raghu Metpally, Ingrid B. Borecki, Kavita Praveen, Jonathan S. Packer, Shannon Bruse, Andrew J. Murphy, Joseph B. Leader, Michael F. Murray, Suganthi Balasubramanian, Neil Stahl, Jeffrey G. Reid, David H. Ledbetter, Dustin N. Hartzel, Kimberly A. Skelding, F. Daniel Davis, Alexander Lopez, Aris Baras, George D. Yancopoulos, Scott Mellis, Robert H. Phillips, John D. Overton, Heather Mason-Suares, Lyndon J. Mitnaul, Daniel R. Lavage
Publikováno v:
Science. 354
Unleashing the power of precision medicine Precision medicine promises the ability to identify risks and treat patients on the basis of pathogenic genetic variation. Two studies combined exome sequencing results for over 50,000 people with their elec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d5e58c2628265e9244c34804e8f7c469
https://doi.org/10.1126/science.aaf6814
https://doi.org/10.1126/science.aaf6814
Publikováno v:
Cancer Research. 72:774-774
Elucidating the molecular mechanism of both primary and acquired resistance to trastuzumab is vital to gaining insight into ways to improve therapeutic outcomes in breast cancer patients. We have previously shown that levels of the 32kDa dopamine and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1e98ec0889a4aac96a55370e01de2b9a
https://doi.org/10.1158/1538-7445.am2012-774
https://doi.org/10.1158/1538-7445.am2012-774